Streetbeat News

Price Targets

CRWD

Cantor Fitzgerald analyst Yi Fu Lee reiterates an Overweight rating on CrowdStrike Holdings (CRWD) with a maintained price target of $400.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:42 pm

HALO

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Halozyme Therapeutics (NASDAQ:HALO) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:41 pm

WEX

Citigroup analyst Ashwin Shirvaikar maintains a Buy rating on WEX (NYSE:WEX) and raises the price target from $240 to $280.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:40 pm

CPAY

Citigroup analyst Peter Christiansen has maintained a Buy rating on Corpay (NYSE:CPAY) and increased the price target from $325 to $355.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:37 pm

TSN

Goldman Sachs analyst Adam Samuelson has maintained a Neutral rating on Tyson Foods (NYSE:TSN) and raised the price target from $49 to $54.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:36 pm

SPOT

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Spotify Technology (NYSE:SPOT) and raised the price target from $235 to $277.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:34 pm

PPC

Goldman Sachs analyst Adam Samuelson maintains a Neutral rating on Pilgrims Pride (NASDAQ:PPC) and raises the price target from $32 to $36.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:32 pm

ITCI

Goldman Sachs analyst Corinne Jenkins has maintained a Neutral rating on Intra-Cellular Therapies (NASDAQ:ITCI) and increased the price target from $67 to $77.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:31 pm

TMO

HSBC analyst Rajesh Kumar has maintained a Buy rating on Thermo Fisher Scientific (TMO) and increased the price target from $630 to $660.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:30 pm

SAVE

Citigroup analyst Stephen Trent has maintained a Sell rating on Spirit Airlines (NYSE:SAVE) and lowered the price target from $4 to $3.85, indicating a bearish outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 3:28 pm